Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Diabetologist
M.B.B.S, M.R.C.P, PG Dip.Diabetes (UK), MD-Diabetes & Endocrine
Diabetologist
M.B.B.S, M.R.C.P, PG Dip.Diabetes (UK), MD-Diabetes & Endocrine
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Diabetologist
MBBS, M.Sc (Diabetes & Endocrinology)
Internal Medicine Specialist
MBBS, MRCPUK
Internal Medicine Specialist
M.B.B.S., Diplomate of American Board (Internal Medicine)
Internal Medicine Specialist
M.B.B.S., Diplomate of American Board (Internal Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
M.B.B.S., M.D.
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), Fellowship in Endocrinology
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), Fellowship in Endocrinology
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures